Actinium Pharmaceuticals, Inc.
MOLECULES AND THEIR DERIVATIVES DIRECTED AGANIST CD45

Abstract:

The present disclosure provides epitopes of CD45, and binding agents such as antibodies, antibody fragments, peptides, and small molecules capable of binding to those epitopes. The present disclosure also provides methods of treating cancers, hematological diseases and disorders, and immune diseases and disorders, using these binding agents.